A prospective clinical trial of the second-look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer.

Goshi NishimuraDaisuke SanoYasuhiro AraiTakashi HatanoHideaki TakahashiTeruhiko TanabeTakashi WadaDaiki MorishitaNobuhiko Oridate

Published in: Cancer medicine (2019)

TOS has the potential for both definitive resection and function preservation with minimal invasiveness. Identification of the risk factors for TOS is advantageous for accurate treatment selection in patients with early T-stage HNC.

Keyphrases

clinical trial
minimally invasive
papillary thyroid
coronary artery bypass
high resolution
squamous cell
study protocol
open label
phase ii
locally advanced
combination therapy
double blind
coronary artery disease
atrial fibrillation
childhood cancer
bioinformatics analysis
placebo controlled